MSD Accesses Korea Oncology Innovation Through State Fund
This article was originally published in PharmAsia News
Executive Summary
In an ongoing series of joint R&D programs with big foreign pharma firms, the Korea Drug Development Fund has tied up with MSD to support the development of novel cancer therapies.